A couple of weeks back, we took a look at how artificial intelligence (AI) has had a transformative impact on cancer research. Today, we take a look at how AI tools help tackle another formidable challenge of modern biotech, Alzheimer’s disease.
“Alzheimer’s is an incredibly complex disease with numerous factors at play. You have the buildup of amyloid plaques, tau tangles, and the loss of connections between nerve cells. If you put yourself in the shoes of a drug maker, how do you choose which one to target, and how do you determine the sequence of events in any given pathway?” said Nadia Harhen, general manager of AI simulation at SandboxAQ.
With traditional research methods alone proving insufficient, AI has emerged in Alzheimer’s research, tackling hurdles in drug discovery and diagnostics. AI’s ability to analyze massive datasets and model biological processes opens opportunities for early detection, understanding disease mechanisms, and even predicting drug efficacy.
The field already benefited from significant improvements, but can AI bring even more to Alzheimer’s research?
read more